Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 514-523

  Landis Piwowar, Kristin R ^a   Milacic, Vesna ^a   Dou, Q Ping ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle progression; Methylated flavonoids; Proteasome inhibitors

Indexed keywords

APIGENIN; CASPASE; CHRYSIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; LUTEOLIN; POLYPHENOL; QUERCETIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; METHYLATION; PRIORITY JOURNAL;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DIET; FLAVONOIDS; G1 PHASE; HUMANS; METHYLATION; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54849416116     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21853     Document Type: Article

References (35)

1. Adams J. 2003. Potential for proteasome inhibition in the treatment of cancer. Drug Discov Today 8:307-315.
2. Almond JB, Cohen GM. 2002. The proteasome: A novel target for cancer chemotherapy. Leukemia 16:433-443.
3. An B, Dou QP. 1996. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 56:438-442.
4. An B, Goldfarb RH, Siman R, Dou QP. 1998. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ 5:1062-1075.
5. Ban JO, Hwang IG, Kim TM, Hwang BY, Lee US, Jeong HS, Yoon YW, Kimz DJ, Hong JT. 2007. Anti-proliferate and pro-apoptotic effects of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyranone through inactivation of NF-kappaB in human colon cancer cells. Arch Pharm Res 30(11):1455-1463.
6. Chen ZJ, Parent L, Maniatis T. 1996. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
7. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP. 2005. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 69:1421-1432.
8. Chen D, Chen MS, Cui QC, Yang H, Dou QP. 2007. Structure-proteasome- inhibitory activity relationships of dietary flavonoids in human cancer cells. Front Biosci 12:1935-1945.
9. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. 2004. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: Role of nuclear factor-kappa B. J Nutr 134:1013-1019.
10. Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP. 2005. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res 7:R897-R908.
11. Daniel KG, Landis-Piwowar KR, Chen D, Wan SB, Chan TH, Dou QP. 2006. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit. Int J Mol Med 18:625-632.
12. Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, Magdelenat H. 1998. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer 77:1103-1107.
13. Dou QP, Li B. 1999. Proteasome inhibitors as potential novel anticancer agents. Drug Resist Updat 2:215-223.
14. Dou QP, Smith DM, Daniel KG, Kazi A. 2003. Interruption of tumor cell cycle progression through proteasome inhibition: Implications for cancer therapy. Prog Cell Cycle Res 5:441-446.
15. Goldberg AL. 1995. Functions of the proteasome: The lysis at the end of the tunnel. Science 268:522-523.
16. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386:463-471.
17. Jiang C, Wang Z, Ganther H, Lu J. 2002. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther 1(12):1059-1066.
18. Kuhn D, Lam WH, Kazi A, Daniel KG, Song S, Chow LM, Chan TH, Dou QP. 2005. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. Front Biosci 10:1010-1023.
19. Landis-Piwowar KR, Kuhn DJ, Wan SB, Chen D, Chan TH, Dou QP. 2005. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs. Int J Mol Med 15:735-742.
20. Landis-Piwowar KR, Wan SB, Wiegand RA, Kuhn DJ, Chan TH, Dou QP. 2007. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J Cell Physiol 213:252-260.
21. Lee LT, Huang YT, Hwang JJ, Lee AY, Ke FC, Huang CJ, Kandaswami C, Lee PP, Lee MT. 2004. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: Effect on invasive potential of human carcinoma cells. Biochem Pharmacol 67:2103-2114.
22. Lee HJ, Wang CJ, Kuo HC, Chou FP, Jean LF, Tseng TH. 2005. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol 203:124-131.
23. Li B, Dou QP. 2000. Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression. Proc Natl Acad Sci USA 97:3850-3855.
24. Lopes UG, Erhardt P, Yao R, Cooper GM. 1997. p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem 272:12893-12896.
25. Lu H, Meng X, Yang CS. 2003. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 31:572-579.
26. Manach C, Donovan JL. 2004. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38:771-785.
27. Mizuno M, Iinuma M, Ohara M, Tanaka T, Iwamasa M. 1991. Chemotaxonomy of the genus citrus based on polymethoxyflavones. Chem Pharm Bull 39:945-949.
28. Nam S, Smith DM, Dou QP. 2001. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276:13322-13330.
29. Ramos S. 2007. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18:427-442.
30. Sim GS, Lee BC, Cho HS, Lee JW, Kim JH, Lee DH, Pyo HB, Moon DC, Oh KW, Yun YP, Hong JT. 2007. Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch Pharm Res 30:290-298.
31. Smith DM, Wang Z, Kazi A, Li LH, Chan TH, Dou QP. 2002. Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med 8:382-392.
32. Smith DM, Daniel KG, Wang Z, Guida WC, Chan TH, Dou QP. 2004. Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design. Proteins 54:58-70.
33. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, Walle UK. 2007. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73:1288-1296.
34. Wen X, Walle T. 2006a. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos 34:1786-1792.
35. Wen X, Walle T. 2006b. Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36:387-397.